New grant program to support 15 nonprofits focused on addressing health disparities in Hartford, CT, and Houston, TX

BLOOMFIELD, Conn., Nov. 26, 2024 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), announced today the first round of grant recipients – comprised of 15 nonprofits across Hartford, CT, and Houston, TX – for The Cigna Group Health Equity Impact Fund. Through this new program, The Cigna Group Foundation will allocate $9 million to nonprofit organizations over the next three years as part of its continuing focus on reducing health disparities.

BLOOMFIELD, Conn., Nov. 11, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group expects to reaffirm projected full year 2024 consolidated adjusted income from operations of at least $28.40 per share and adjusted EPS growth of at least 10% in 2025. Additionally, in light of recent and persistent speculation, The Cigna Group expects to communicate that the company is not pursuing a combination with Humana Inc. The Cigna Group remains committed to its established M&A criteria and would only consider acquisitions that are strategically aligned, financially attractive, and have a high probability to close.

Infirmary's hospitals, facilities and doctors on Alabama's Gulf Coast are now in-network for Cigna Healthcare MA customers

MOBILE, Ala., Nov. 1, 2024 /PRNewswire/ -- Cigna Healthcare and Mobile-based Infirmary Health have reached an agreement that allows Cigna Healthcare's Medicare Advantage (MA) customers to have in-network access to Infirmary Health's hospitals, facilities and doctors.

BLOOMFIELD, Conn., Oct. 31, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today reported strong third quarter 2024 results demonstrating focused execution across Evernorth Health Services and Cigna Healthcare.

BLOOMFIELD, Conn., Oct. 23, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on December 19, 2024 to shareholders of record as of the close of business on December 4, 2024.

About The Cigna Group

The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions, and has more than 187 million customer relationships around the world. Learn more at thecignagroup.com.

54 community-based organizations receive funds to support the dietary needs of older adults

BLOOMFIELD, Conn., Oct. 21, 2024 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), is investing $600,000 in community-based organizations this fall to address food insecurity among older Americans. Collectively, the funds are expected to impact more than 1.4 million people in need.

BLOOMFIELD, Conn., Oct. 3, 2024  /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2024 financial results on Thursday, October 31, 2024, and will host a conference call the same day.

Third quarter 2024 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action

ST. LOUIS, Sept. 20, 2024 /PRNewswire/ -- Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today issued the following statement in response to the Federal Trade Commission's reckless insulin action:

Attributable to Andrea Nelson, Chief Legal Officer, The Cigna Group:

Convene Business, Government and Community Leaders to Discuss Ways to Address the Mental Health Crisis Impacting Employees Across America

WASHINGTON, Sept. 18, 2024 /PRNewswire/ -- Business Roundtable and The Cigna Group brought together senior business executives, federal policymakers and community leaders last night for a Workforce Mental Health Summit in the nation's capital. The event was part of the Business Roundtable Mental Health Initiative, a CEO-led effort to help companies promote and support employee mental health, championed by David M. Cordani, Chairman and CEO of The Cigna Group (NYSE:CI). During the event, leaders in business and government provided perspectives on the impacts of the mental health crisis and strategies to ensure a healthy and productive U.S. workforce.

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients

ST. LOUIS, Sept. 17, 2024 /PRNewswire/ -- In a lawsuit filed in federal court in Missouri, Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), demanded that the Federal Trade Commission ("FTC" or the "Commission") retract its July 2024 report, which is filled with false and misleading claims about the pharmacy benefit management (PBM) industry and fails to serve the interests of American consumers.

BLOOMFIELD, Conn., Sept. 12, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Matt Perlberg, President of the Evernorth Health Services pharmacy and care delivery businesses, will present at the Bernstein Healthcare 1:1 Forum on September 24, 2024, in New York, NY.

The Cigna Group's presentation is expected to begin at approximately 9:00 a.m. ET. A live webcast of the presentation will be available at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Group's website.

BLOOMFIELD, Conn., Sept. 12, 2024 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), launched an "E-Treatment" option through MDLIVE by Evernorth. Beginning this month, customers have quick, flexible access to urgent care from board-certified doctors, without any direct interaction via phone or video. For many common, lower-risk conditions, such as allergies, eye or ear infections, urinary tract infections, and some respiratory illnesses like the flu, customers can submit a virtual clinical interview through the MDLIVE portal, and typically within one hour, they will receive their diagnoses and personalized treatment plans.

BLOOMFIELD, Conn., Sept. 5, 2024 /PRNewswire/ -- Evernorth Health Services announced that it plans to have a Stelara biosimilar available for $0 out of pocket for eligible patients of its specialty pharmacy, Accredo, beginning in early 2025. The interchangeable biosimilar will be produced for Evernorth's affiliate private label distributor, Quallent Pharmaceuticals. It will be available at $0 out of pocket for most patients through Quallent's copay assistance program. This program is expected to save individual patients around $4,000 on average per year.

BLOOMFIELD, Conn., Aug. 15, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that David Cordani, Chairman and Chief Executive Officer, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, in New York, NY.

The Cigna Group's presentation is expected to begin at approximately 10:45 a.m. ET. A live webcast of the presentation will be available at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Group's website.

BLOOMFIELD, Conn., Aug. 12, 2024  /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), announced today a new grant program that will commit $9 million over three years to help improve the mental health and well-being of military veterans, with a first-year focus on housing stability among this specific population.

BLOOMFIELD, Conn., July 24, 2024  /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on September 19, 2024 to shareholders of record as of the close of business on September 4, 2024.

About The Cigna Group

The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions, and has more than 187 million customer relationships around the world. Learn more at thecignagroup.com.

Commits $9M in Grants to Reduce Health Disparities beginning with the Houston, TX and Hartford, CT Communities

BLOOMFIELD, Conn., July 22, 2024 /PRNewswire/ -- As part of its ongoing commitment to community health and vitality, global health company The Cigna Group (NYSE: CI) today announced the creation of The Cigna Group Health Equity Impact Fund, a community program in which The Cigna Group Foundation will commit $9 million over three years to reduce key health barriers by specifically targeting health disparities most prevalent in local communities.

Commits $9M in Grants to Reduce Health Disparities Beginning in the Hartford, CT and Houston, TX Communities

BLOOMFIELD, Conn., July 22, 2024 /PRNewswire/ -- As part of its ongoing commitment to community health and vitality, global health company The Cigna Group (NYSE: CI) today announced the creation of The Cigna Group Health Equity Impact Fund, a community program in which The Cigna Group Foundation will commit $9 million over three years to reduce key health barriers by specifically targeting health disparities most prevalent in local communities.